EQL Pharma AB (publ) (STO:EQL)
26.30
+1.15 (4.57%)
At close: Aug 14, 2026
EQL Pharma AB Employees
EQL Pharma AB had 23 employees as of March 31, 2026. The number of employees increased by 2 or 9.52% compared to the previous year.
Employees
23
Change
2
Growth
9.52%
Revenue / Employee
6.65M SEK
Profits / Employee
-216.05K SEK
Market Cap
776.63M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 23 | 2 | 9.52% |
| Dec 31, 2025 | 55 | 27 | 96.43% |
| Sep 30, 2025 | 54 | 34 | 170.00% |
| Jun 30, 2025 | 20 | -2 | -9.09% |
| Mar 31, 2025 | 21 | 0 | - |
| Dec 31, 2024 | 28 | 9 | 47.37% |
| Sep 30, 2024 | 20 | 2 | 11.11% |
| Jun 30, 2024 | 22 | 4 | 22.22% |
| Mar 31, 2024 | 21 | 3 | 16.67% |
| Dec 31, 2023 | 19 | 6 | 46.15% |
| Sep 30, 2023 | 18 | 4 | 28.57% |
| Jun 30, 2023 | 18 | 4 | 28.57% |
| Mar 31, 2023 | 18 | 5 | 38.46% |
| Dec 31, 2022 | 13 | 2 | 18.18% |
| Sep 30, 2022 | 14 | 3 | 27.27% |
| Jun 30, 2022 | 14 | 3 | 27.27% |
| Mar 31, 2022 | 13 | 3 | 30.00% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioGaia AB | 251 |
| Orexo AB | 61 |
| Enzymatica AB | 18 |
| Cinclus Pharma Holding AB | 17 |
| Nanexa AB | 16 |
| Cereno Scientific AB | 10 |
| Newbury Pharmaceuticals AB | 7 |
| Moberg Pharma AB | 5 |
EQL Pharma AB News
- 8 days ago - EQL Pharma AB Transcript: Q1 26/27 - Transcripts
- 8 days ago - EQL Pharma AB Quarterly report: Q1 2027 - Filings
- 8 days ago - EQL Pharma AB Slides: Q1 2027 - Filings
- 3 months ago - EQL Pharma AB Transcript: Q4 25/26 - Transcripts
- 3 months ago - EQL Pharma AB Quarterly report: Q4 2026 - Filings
- 3 months ago - EQL Pharma AB Annual report: Q4 2026 - Filings
- 6 months ago - EQL Pharma AB Transcript: Q3 25/26 - Transcripts
- 6 months ago - EQL Pharma AB Quarterly report: Q3 2026 - Filings